ACUTE LYMPHOBLASTIC LEUKEMIA
Clinical trials for ACUTE LYMPHOBLASTIC LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new ACUTE LYMPHOBLASTIC LEUKEMIA trials appear
Sign up with your email to follow new studies for ACUTE LYMPHOBLASTIC LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Targeted attack on cancer cells during transplant shows promise
Disease control TerminatedThis study tested whether adding a targeted drug called inotuzumab ozogamicin to a stem cell transplant regimen could better control leukemia and lymphoma. The drug is designed to seek out and kill cancer cells that have a specific marker (CD22). Researchers enrolled 15 patients …
Matched conditions: ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New drug trial aims to control tough blood cancer in adults
Disease control TerminatedThis study aimed to find the right dose and check the safety of a drug called calaspargase pegol for adults with a type of blood cancer called acute lymphoblastic leukemia (ALL). It was for adults aged 22 to 55 who were newly diagnosed and had not received other treatments. The t…
Matched conditions: ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE2, PHASE3 • Sponsor: Institut de Recherches Internationales Servier • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
New Two-Pronged immune cell attack tested for tough leukemias
Disease control TerminatedThis early-phase study tested the safety of a new type of CAR-T cell therapy designed to fight B-cell acute lymphoblastic leukemia (ALL) that has come back or not responded to other treatments. The therapy involved taking a patient's own immune cells, modifying them in a lab to r…
Matched conditions: ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE1 • Sponsor: Medical College of Wisconsin • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
New hope for kids battling leukemia that Won't stay away
Disease control TerminatedThis study tested whether adding a new drug called isatuximab to standard chemotherapy could help children whose acute leukemia had come back or not responded to previous treatment. It involved 67 children and young adults, from infants to under 18 years old. The main goal was to…
Matched conditions: ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE2 • Sponsor: Sanofi • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC
-
Targeted attack on stubborn childhood leukemia cells
Disease control TerminatedThis study tested a targeted drug called Inotuzumab for children and young adults with a specific type of leukemia (B-ALL) who still had small amounts of cancer cells after initial treatment. The goal was to see if this drug could eliminate these remaining cells to help prevent t…
Matched conditions: ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE2 • Sponsor: St. Jude Children's Research Hospital • Aim: Disease control
Last updated Mar 18, 2026 14:41 UTC
-
Simple supplements aim to ease dangerous drug side effect in leukemia patients
Symptom relief TerminatedThis study tested whether two common nutritional supplements could help treat a serious liver side effect caused by certain leukemia medications. It involved adults with acute lymphoblastic leukemia who developed high liver enzymes during treatment. The goal was to see if taking …
Matched conditions: ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated Mar 13, 2026 15:06 UTC